Marketing-authorisation holder · United Kingdom
Glaxo Group Limited
19 medicines in 3 countries, as authorisation holder.
Loading your page…
Marketing-authorisation holder · United Kingdom
19 medicines in 3 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
19 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AVAMYS 27,5 mcg/PULVERIZACION PARA SUSPENSION NASAL27,5 µg · Suspensión para pulverización nasal | Fluticasone | Spain | Marketed | 2011 |
| AVAMYS 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL27,5 µg · Suspensión para pulverización nasal | Fluticasone | Spain | Marketed | 2018 |
| AVAMYS 27,5 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL27,5 µg · Suspensión para pulverización nasal | Fluticasone | Spain | Authorised | 2018 |
| AVAMYS 27,5mcg/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL27,5 µg · Suspensión para pulverización nasal | Fluticasone | Spain | Authorised | 2012 |
| AVAMYS 27,5mcg/pulverizacion suspension para pulverizacion nasal27,5 µg · Suspensión para pulverización nasal | Fluticasone | Spain | Authorised | 2015 |
| RELVAR ELLIPTA 92 MICROGRAMOS/22 MICROGRAMOS POLVO PARA INHALACION (UNIDOSIS)25 µg + 100 µg · Polvo para inhalación (unidosis) | Vilanterol trifenatato, Fluticasone | Spain | Authorised | 2018 |
| Agenerase | Amprenavir | EU (EMA) | Withdrawn | 2000 |
| Alisade | Fluticasone | EU (EMA) | Cancelled | 2008 |
| ALLI 27 mg COMPRIMIDOS MASTICABLES27 mg · Comprimido masticable | Orlistat | Spain | Withdrawn | 2011 |
| ALLI 27 mg COMPRIMIDOS MASTICABLES27 mg · Comprimido masticable | Orlistat | Spain | Withdrawn | 2011 |
| Altargo | Retapamulin | EU (EMA) | Withdrawn | 2007 |
| AVAMYS 27,5mcg/puf27.5mcg · Spray nazal - susp. | Fluticasone | Romania | unknown | |
| BENLYSTA 120mg120mg · Pulb. pt. conc. pt. sol. perf. | Belimumab | Romania | unknown | |
| BENLYSTA 400mg400mg · Pulb. pt. conc. pt. sol. perf. | Belimumab | Romania | unknown | |
| Bosatria | Mepolizumab | EU (EMA) | Refused | |
| Quixidar | Fondaparinux | EU (EMA) | Withdrawn | 2002 |
| Trobalt | Retigabine | EU (EMA) | Withdrawn | 2011 |
| ZEFFIX 100mg100mg · Compr. film. | Lamivudine | Romania | unknown | |
| Zunrisa | Casopitant | EU (EMA) | Refused |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 8 | 6 | 2 | CompaniesAll medicines |
| European Union (EMA) | 7 | 0 | 7 | CompaniesAll medicines |
| Romania | 4 | 0 | 4 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.